New pump delivers chemo straight to brain tumors in groundbreaking trial
NCT ID NCT06666712
Summary
This early-stage study is testing the safety of a new delivery method for the chemotherapy drug topotecan in patients with a specific type of recurrent brain tumor. A small pump implanted under the skin delivers the drug directly to the tumor through a thin tube, aiming to bypass the body's natural barriers and control the cancer. The main goal is to see if this prolonged, direct delivery is safe and how well the drug spreads within the tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR, RECURRENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
RECRUITINGNew York, New York, 10032, United States
Contact
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.